Host an event in support of Brain Tumour Foundation of Canada - Do it Your Way
The current treatments for brain cancer do not work well and cause a lot of side-effects. This highlights the need to develop better treatments. There are several types of brain tumors. They differ in their age of onset, aggressiveness, and localization within the brain.
Attending school not only allows students to learn but the opportunity to develop interests, connect with peers, and form lifelong bonds. With your generous support we will explore pediatric brain tumour survivors' and their families' experience re-entering the education system after a cancer diagnosis.
Through their remarkable generosity, the Brain Tumour Foundation of Canada has enabled our interdisciplinary research group to develop artificial intelligence technologies to help discover new therapies against recurrent glioblastoma.
We hope this research will lead to the initiation of new clinical trials to optimize and expand the subset of patients with brain metastases who will derive the greatest clinical benefit from this therapy.
This research project, which has been 10 years in the making, is progressing very well, and will continue to do so thanks to this generous grant. Rest assured that we will continue to work tirelessly to improve the care of brain tumour patients.
The BTFC funding will allow us to start applying the most innovative machine learning methods to ensure patients with brain tumours in Ontario – including children – receive the highest quality radiotherapy possible.
I would like to thank the Brain Tumour Foundation of Canada for supporting this important work. Our project represents a novel collaboration between experts in translational medicine, clinical epidemiology, and neuro-oncology survivorship.
This award will allow our research team to better understand how brain metastases affect our patients’ ability to live meaningful and productive lives. We have the opportunity to study in great detail the unique challenges faced our patients and the factors that most strongly contribute to their psychological and functional well-being.
Thanks to the generous funding provided by the Brain Tumour Foundation of Canada and DUNN with Cancer, we are now poised to advance our research and delve deeper into elucidating key epigenetic factors that drive the progression of GBM and its resistance to therapies.
We are so grateful to the BTFC and DUNN with Cancer for the many levels of support they provide to the brain cancer research community. BTFC supports new ideas, innovation and transformative thinking about incredibly challenging problems like how to develop new treatments for a highly treatment-resistant brain tumour such as GBM.
This funding has enabled us to continue the promising research on targeting pannexin channels to stop communication between cells and reduce the growth and spread of glioblastoma tumours. Thanks to this funding we can support the technicians, graduate students, and expensive supplies we need to use in the lab to carry out this research.
On behalf of my collaborating investigators and myself, I would like to express immense gratitude to all of you for supporting our research that we know will have profound impact on the practice and delivery of care for pediatric brain tumour patients across Canada.
There are so many ways you can help make a difference in the lives of patients and families today.
Reach out for support, education and information and to learn about research.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
